CareLit Fachartikel
Evaluation of combined biomarkers for tumor response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)
H Ramdani, M Falk, S Schatz, LC Heukamp, M Tiemann, E Schuuring, H Groen, F Griesinger · Pneumologie · 2020 · Heft S 01 S 01
Dokument
1214619
CareLit-ID
Jahr
2020
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Evaluation of combined biomarkers for tumor response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)
Schlagworte
Biomarkers
Tumor
Pneumologie